Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Cervical Cancer, January 2018

Free Subscription


Retrieve all available abstracts of the following 186 articles:
HTML format


Single Articles

  1. AL-HAMMADI FA, Al-Tahri F, Al-Ali A, Nair SC, et al
    Limited Understanding of Pap Smear Testing among Women, a Barrier to Cervical Cancer Screening in the United Arab Emirates
    Asian Pac J Cancer Prev. 2017;18:3379-3387.
    Abstract     Related articles   

  2. HAUGE A, Wegner CS, Gaustad JV, Simonsen TG, et al
    Diffusion-weighted MRI-derived ADC values reflect collagen I content in PDX models of uterine cervical cancer.
    Oncotarget. 2017;8:105682-105691.
    Abstract     Related articles   

  3. JIN Y, Kim SC, Kim HJ, Ju W, et al
    Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer.
    Oncotarget. 2017;8:105425-105439.
    Abstract     Related articles   

  4. VATTAI A, Cavailles V, Sixou S, Beyer S, et al
    Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer.
    Oncotarget. 2017;8:105356-105371.
    Abstract     Related articles   

  5. SEN P, Ganguly P, Ganguly N
    Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer.
    Oncol Lett. 2018;15:11-22.
    Abstract     Related articles   

  6. ZHAI L, Li Y, Lan X, Ai L, et al
    MicroRNA-10a-5p suppresses cancer proliferation and division in human cervical cancer by targeting BDNF.
    Exp Ther Med. 2017;14:6147-6151.
    Abstract     Related articles   

  7. GONG P, Hu C, Zhou X, Wang R, et al
    TAT-mediated si-hWAPL inhibits the invasion and metastasis of cervical cancer stem cells.
    Exp Ther Med. 2017;14:5452-5458.
    Abstract     Related articles   

  8. WEI Y, Dong J, Li F, Wei Z, et al
    Knockdown of SLC39A7 suppresses cell proliferation, migration and invasion in cervical cancer.
    EXCLI J. 2017;16:1165-1176.
    Abstract     Related articles   

  9. MAZDZIARZ A, Wygledowski J, Osuch B, Jagielska B, et al
    New directions in cervical cancer prophylaxis worldwide and in Poland - Case study of the Polish rural female population.
    Ann Agric Environ Med. 2017;24:592-595.
    Abstract     Related articles   

  10. BECERRA-CULQUI TA, Lonky NM, Chen Q, Chao CR, et al
    Patterns and correlates of cervical cancer screening initiation in a large integrated healthcare system.
    Am J Obstet Gynecol. 2017 Dec 22. pii: S0002-9378(17)32708.
    Abstract     Related articles   

  11. ERKU DA, Netere AK, Mersha AG, Abebe SA, et al
    Comprehensive knowledge and uptake of cervical cancer screening is low among women living with HIV/AIDS in Northwest Ethiopia.
    Gynecol Oncol Res Pract. 2017;4:20.
    Abstract     Related articles   

  12. UMEZAWA R, Murakami N, Nakamura S, Wakita A, et al
    Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.
    Brachytherapy. 2017 Dec 21. pii: S1538-4721(17)30532.
    Abstract     Related articles   

  13. CIHORIC N, Tsikkinis A, Vlaskou Badra E, Glatzer M, et al
    Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study.
    Radiat Oncol. 2017;12:202.
    Abstract     Related articles   

    Patients with newly diagnosed cervical cancer should be screened for anal human papilloma virus and anal dysplasia: Results of a pilot study using a STELLA computer simulation and economic model.
    Papillomavirus Res. 2017;5:38-45.
    Abstract     Related articles   

  15. YE GL, Du DL, Jin LJ, Wang LL, et al
    Sensitization of TRAIL-resistant cervical cancer cells through combination of TRAIL and fucoxanthin treatments.
    Eur Rev Med Pharmacol Sci. 2017;21:5594-5601.
    Abstract     Related articles   

  16. WEI H, Zhang JJ, Tang QL
    MiR-638 inhibits cervical cancer metastasis through Wnt/beta-catenin signaling pathway and correlates with prognosis of cervical cancer patients.
    Eur Rev Med Pharmacol Sci. 2017;21:5587-5593.
    Abstract     Related articles   

  17. ZHAO Y, Liu X, Lu YX
    MicroRNA-143 regulates the proliferation and apoptosis of cervical cancer cells by targeting HIF-1alpha.
    Eur Rev Med Pharmacol Sci. 2017;21:5580-5586.
    Abstract     Related articles   

  18. TEOH D, Shaikh R, Vogel RI, Zoellner T, et al
    A Cross-Sectional Review of Cervical Cancer Messages on Twitter During Cervical Cancer Awareness Month.
    J Low Genit Tract Dis. 2018;22:8-12.
    Abstract     Related articles   

  19. HAMMER A, Hee L, Blaakaer J, Gravitt P, et al
    Temporal Patterns of Cervical Cancer Screening Among Danish Women 55 Years and Older Diagnosed With Cervical Cancer.
    J Low Genit Tract Dis. 2018;22:1-7.
    Abstract     Related articles   

    Therapy-free interval has prognostic value in patients with recurrent cervical cancer treated with chemotherapy following definitive concurrent chemoradiotherapy: methodological issues.
    Arch Gynecol Obstet. 2017 Dec 21. pii: 10.1007/s00404-017-4629.
    Abstract     Related articles   

  21. WU SG, Zhang WW, He ZY, Sun JY, et al
    Comparison of survival outcomes between radical hysterectomy and definitive radiochemotherapy in stage IB1 and IIA1 cervical cancer.
    Cancer Manag Res. 2017;9:813-819.
    Abstract     Related articles   

  22. ZHEN S, Li X
    Oncogenic Human Papillomavirus: Application of CRISPR/Cas9 Therapeutic Strategies for Cervical Cancer.
    Cell Physiol Biochem. 2017;44:2455-2466.
    Abstract     Related articles   

  23. RAFAEL RMR, Moura ATMS
    Severe intimate partner physical violence as a risk factor for inadequate cervical cancer screening.
    Cad Saude Publica. 2017;33:e00074216.
    Abstract     Related articles   

  24. WU MH, Lin CL, Chiou HL, Yang SF, et al
    Praeruptorin A Inhibits Human Cervical Cancer Cell Growth and Invasion by Suppressing MMP-2 Expression and ERK1/2 Signaling.
    Int J Mol Sci. 2017;19.
    Abstract     Related articles   

  25. YANG X, Cheng Y, Li C
    The role of TLRs in cervical cancer with HPV infection: a review.
    Signal Transduct Target Ther. 2017;2:17055.
    Abstract     Related articles   

  26. OH J, Seol KH, Lee HJ, Choi YS, et al
    Prophylactic extended-field irradiation with concurrent chemotherapy for pelvic lymph node-positive cervical cancer.
    Radiat Oncol J. 2017 Dec 23. pii: roj.2017.00367. doi: 10.3857/roj.2017.00367.
    Abstract     Related articles   

  27. WANG W, Meng Q, Hou X, Lian X, et al
    Efficacy and toxicity of image-guided intensity-modulated radiation therapy combined with dose-escalated brachytherapy for stage IIB cervical cancer.
    Oncotarget. 2017;8:102965-102973.
    Abstract     Related articles   

  28. WASIM L, Chopra M
    Synergistic anticancer effect of panobinostat and topoisomerase inhibitors through ROS generation and intrinsic apoptotic pathway induction in cervical cancer cells.
    Cell Oncol (Dordr). 2017 Dec 19. pii: 10.1007/s13402-017-0366.
    Abstract     Related articles   

  29. VAJDA R, Arvane Egri C, Kovacs A, Budai A, et al
    [Quality and performance indicators of the pilot program for cervical cancer screening by health visitors].
    Magy Onkol. 2017;61:361-367.
    Abstract     Related articles   

  30. ILIYASU AM, Fatichah C
    A Quantum Hybrid PSO Combined with Fuzzy k-NN Approach to Feature Selection and Cell Classification in Cervical Cancer Detection.
    Sensors (Basel). 2017;17.
    Abstract     Related articles   

  31. WANG D, Li Q, Li Y, Wang H, et al
    The role of MCM5 expression in cervical cancer: Correlation with progression and prognosis.
    Biomed Pharmacother. 2017;98:165-172.
    Abstract     Related articles   

  32. KANGMENNAANG J, Onyango EO, Luginaah I, Elliott SJ, et al
    The next Sub Saharan African epidemic? A case study of the determinants of cervical cancer knowledge and screening in Kenya.
    Soc Sci Med. 2017;197:203-212.
    Abstract     Related articles   

  33. RONCO G, Baussano I
    Causal system modelling of cervical cancer screening.
    Lancet Public Health. 2017;2:e61-e62.
    Abstract     Related articles   

  34. GUIDO R
    Cervical Cancer Screening.
    Clin Obstet Gynecol. 2017 Dec 15. doi: 10.1097/GRF.0000000000000336.
    Abstract     Related articles   

  35. ZHOU WJ, Yang HL, Chang KK, Meng Y, et al
    Human thymic stromal lymphopoietin promotes the proliferation and invasion of cervical cancer cells by downregulating microRNA-132 expression.
    Oncol Lett. 2017;14:7910-7916.
    Abstract     Related articles   

  36. BOU-ORM IR, Sakr RE, Adib SM
    Cervical cancer screening among Lebanese women.
    Rev Epidemiol Sante Publique. 2017 Dec 14. pii: S0398-7620(17)30526.
    Abstract     Related articles   

  37. GUO F, Chen YZ, Li L, Chen C, et al
    Long non-coding RNA XLOC_008466 acts as an oncogenic molecular in cervical cancer tumorigenesis.
    Biomed Pharmacother. 2017;98:88-94.
    Abstract     Related articles   

  38. CASTANON A, Sasieni P
    Is the recent increase in cervical cancer in women aged 20-24years in England a cause for concern?
    Prev Med. 2017;107:21-28.
    Abstract     Related articles   

  39. REN CC, Yang L, Liu L, Chen YN, et al
    Effects of shRNA-mediated Silencing of PSMA7 on Cell Proliferation and Vascular Endothelial Growth Factor Expression via the Ubiquitin-Proteasome Pathway in Cervical Cancer.
    J Cell Physiol. 2017 Dec 16. doi: 10.1002/jcp.26408.
    Abstract     Related articles   

  40. LIU J, Ni S
    Association between genetic polymorphisms in the promoters of let-7 and risk of cervical squamous cell carcinoma.
    Gene. 2018;642:256-260.
    Abstract     Related articles   

  41. LYTVYNENKO M, Bocharova T, Zhelezniakova N, Narbutova T, et al
    Georgian Med News. 2017;:12-17.
    Abstract     Related articles   

  42. KRUAKAEW S, Seeka C, Lhinhatrakool T, Thongnest S, et al
    Cytotoxic Cardiac Glycoside Constituents of Vallaris glabra Leaves.
    J Nat Prod. 2017;80:2987-2996.
    Abstract     Related articles   

  43. DROLET M, Laprise JF, Brotherton JML, Donovan B, et al
    The impact of human papillomavirus catch-up vaccination in Australia: Implications for introduction of multiple age cohort vaccination and post-vaccination data interpretation.
    J Infect Dis. 2017 Sep 12. doi: 10.1093.
    Abstract     Related articles   

  44. GRAVITT PE, Winer RL
    Natural History of HPV Infection across the Lifespan: Role of Viral Latency.
    Viruses. 2017;9.
    Abstract     Related articles   

  45. TROPE A, Engesaeter B, Nygard M, Andreassen T, et al

    Tidsskr Nor Laegeforen. 2017;137.
    Abstract     Related articles   

  46. LIU M, An J, Huang M, Wang L, et al
    MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas.
    Mol Carcinog. 2018;57:32-43.
    Abstract     Related articles   

  47. BURTON ER, Sorosky JI
    Recognition and Therapeutic Options for Malignancy of the Cervix and Uterus.
    Obstet Gynecol Clin North Am. 2017;44:195-206.
    Abstract     Related articles   

  48. SUN Y, Peng S, Yang A, Farmer E, et al
    Coinjection of IL2 DNA enhances E7-specific antitumor immunity elicited by intravaginal therapeutic HPV DNA vaccination with electroporation.
    Gene Ther. 2017;24:408-415.
    Abstract     Related articles   

  49. GANTA V, Moonie S, Patel D, Hunt AT, et al
    Timely reminder interventions to improve annual Papanicolaou (Pap) smear rates among HIV-infected women in an outpatient center of southern Nevada: a short report.
    AIDS Care. 2017;29:1099-1101.
    Abstract     Related articles   

  50. JACOB D, Lamberto M, DeSouza Lawrence L, Mourtada F, et al
    Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
    Brachytherapy. 2017;16:624-629.
    Abstract     Related articles   

  51. EID W, Abdel-Rehim W
    Neferine Enhances the Antitumor Effect of Mitomycin-C in Hela Cells Through the Activation of p38-MAPK Pathway.
    J Cell Biochem. 2017;118:3472-3479.
    Abstract     Related articles   

  52. PIZZO K, Arnold C, Wispelwey B
    Actinomyces neuii Causing Vertebral Osteomyelitis.
    Am J Med Sci. 2017;353:407-410.
    Abstract     Related articles   

  53. ZHOU J, Wu SG, Sun JY, Li FY, et al
    The effect of local treatment modalities in patients with early-stage adenocarcinoma of the uterine cervix: A population-based analysis.
    Int J Surg. 2017;41:16-22.
    Abstract     Related articles   

  54. GOTTVALL M, Stenhammar C, Grandahl M
    Parents' views of including young boys in the Swedish national school-based HPV vaccination programme: a qualitative study.
    BMJ Open. 2017;7:e014255.
    Abstract     Related articles   

  55. FILHO SMA, Bertoni N, Brant AC, Vidal JPCB, et al
    Methylation at 3'LCR of HPV16 can be affected by patient age and disruption of E1 or E2 genes.
    Virus Res. 2017;232:48-53.
    Abstract     Related articles   

  56. THAKER PH, Salani R, Brady WE, Lankes HA, et al
    A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852).
    Ann Oncol. 2017;28:505-511.
    Abstract     Related articles   

  57. ZHANG Y, Jin LP
    Effects of TSLP on obstetrical and gynecological diseases.
    Am J Reprod Immunol. 2017;77.
    Abstract     Related articles   

  58. CHRISTENSEN ND, Budgeon LR, Cladel NM, Hu J, et al
    Recent advances in preclinical model systems for papillomaviruses.
    Virus Res. 2017;231:108-118.
    Abstract     Related articles   

  59. YANG A, Farmer E, Lin J, Wu TC, et al
    The current state of therapeutic and T cell-based vaccines against human papillomaviruses.
    Virus Res. 2016 Dec 5. pii: S0168-1702(16)30556.
    Abstract     Related articles   

  60. SCHELLENBACHER C, Roden RB, Kirnbauer R
    Developments in L2-based Human Papillomavirus (HPV) Vaccines.
    Virus Res. 2016 Nov 23. pii: S0168-1702(16)30528.
    Abstract     Related articles   

  61. SONG Y, Tan EL, Jiang X, Cheng JZ, et al
    Accurate Cervical Cell Segmentation from Overlapping Clumps in Pap Smear Images.
    IEEE Trans Med Imaging. 2017;36:288-300.
    Abstract     Related articles   

  62. FIELDING S, Rothnie K, Gray NM, Little J, et al
    Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial.
    Psychooncology. 2017;26:476-483.
    Abstract     Related articles   

  63. CHORLEY AJ, Marlow LA, Forster AS, Haddrell JB, et al
    Experiences of cervical screening and barriers to participation in the context of an organised programme: a systematic review and thematic synthesis.
    Psychooncology. 2017;26:161-172.
    Abstract     Related articles   

  64. EL SAYED ME, Bahadur YA, Hassouna AH, Fawzy EE, et al
    Outcome of cervix uteri cancer patients: Clinical treatment results and toxicity profile in a retrospective study from Saudi Arabia.
    Asia Pac J Clin Oncol. 2017;13:e364-e372.
    Abstract     Related articles   

  65. SLAMA J
    [Current limits of cervical cancer prevention in the Czech republic].
    Ceska Gynekol. 2017;82:482-486.
    Abstract     Related articles   

  66. XIE X, Song K, Cui B, Jiang J, et al
    A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.
    Int J Clin Oncol. 2018 Jan 3. pii: 10.1007/s10147-017-1225.
    Abstract     Related articles   

  67. ZHU X, Zhou L, Li R, Shen Q, et al
    AGER promotes proliferation and migration in cervical cancer.
    Biosci Rep. 2018 Jan 3. pii: BSR20171329. doi: 10.1042/BSR20171329.
    Abstract     Related articles   

  68. PLISSONNIER ML, Fauconnet S, Bittard H, Mougin C, et al
    Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells.
    Oncotarget. 2017;8:107744-107762.
    Abstract     Related articles   

  69. WANG Y, Tian Y
    miR-206 inhibits cell proliferation, migration, and invasion by targeting BAG3 in human cervical cancer.
    Oncol Res. 2018 Jan 2. doi: 10.3727/096504017X15143731031009.
    Abstract     Related articles   

  70. SHI X, Yuan N, Zhang S, Yuan F, et al
    MicroRNA-379 suppresses cervical cancer cell proliferation and invasion by directly targeting V-crk avian sarcoma virus CT10 oncogene homolog-like.
    Oncol Res. 2018 Jan 2. doi: 10.3727/096504017X15140534417184.
    Abstract     Related articles   

  71. NGWENYA D, Huang SL
    Knowledge, attitude and practice on cervical cancer and screening: a survey of men and women in Swaziland.
    J Public Health (Oxf). 2017 Dec 27. pii: 4779874. doi: 10.1093.
    Abstract     Related articles   

  72. GULER OC, Torun N, Yyldyrym BA, Onal C, et al
    Pretreatment metabolic tumor volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy.
    Br J Radiol. 2018 Jan 2:20170552. doi: 10.1259/bjr.20170552.
    Abstract     Related articles   

  73. CHEN JW, Chen HB, He Q, Liao YL, et al
    [Rectal toxicity prediction based on accurate rectal surface dose summation for cervical cancer radiotherapy].
    Nan Fang Yi Ke Da Xue Xue Bao. 2017;37:1626-1631.
    Abstract     Related articles   

  74. JIN Y, Qiu S, Shao N, Zheng J, et al
    Fucoxanthin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Synergistically Promotes Apoptosis of Human Cervical Cancer Cells by Targeting PI3K/Akt/NF-kappaB Signaling Pathway.
    Med Sci Monit. 2018;24:11-18.
    Abstract     Related articles   

  75. MEI Y, Peng C, Liu YB, Wang J, et al
    Silencing RIF1 decreases cell growth, migration and increases cisplatin sensitivity of human cervical cancer cells.
    Oncotarget. 2017;8:107044-107051.
    Abstract     Related articles   

  76. MATSUO K, Shimada M, Yokota H, Satoh T, et al
    Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer.
    Oncotarget. 2017;8:106866-106875.
    Abstract     Related articles   

  77. EO WK, Kwon BS, Kim KH, Kim HY, et al
    Monocytosis as a prognostic factor for survival in stage IB and IIA cervical cancer.
    J Cancer. 2018;9:64-70.
    Abstract     Related articles   

  78. YIM GW, Eoh KJ, Chung YS, Kim SW, et al
    Perioperative Outcomes of 3-Arm Versus 4-Arm Robotic Radical Hysterectomy in Patients with Cervical Cancer.
    J Minim Invasive Gynecol. 2017 Dec 26. pii: S1553-4650(17)31338.
    Abstract     Related articles   

  79. SKORZYNSKA H, Krawczyk-Suszek M, Kulik TB, Pacian A, et al
    Attitudes of women after the age of 50 towards preventive screening.
    Ann Agric Environ Med. 2017;24:624-627.
    Abstract     Related articles   

  80. OKONOGI N, Wakatsuki M, Kato S, Shiba S, et al
    Long-term Outcomes of Carbon-ion Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Uterine Cervix.
    Anticancer Res. 2018;38:457-463.
    Abstract     Related articles   

  81. KYRGIOU M, Athanasiou A, Kalliala IEJ, Paraskevaidi M, et al
    Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease.
    Cochrane Database Syst Rev. 2017;11:CD012847.
    Abstract     Related articles   

  82. MOSES A, Mwafongo A, Chikasema M, Kafantenganji L, et al
    Risk factors for common cancers among patients at Kamuzu Central Hospital in Lilongwe, Malawi: A retrospective cohort study.
    Malawi Med J. 2017;29:136-141.
    Abstract     Related articles   

  83. LEE HJ, Lee JJ, Park JY, Kim JH, et al
    Prognostic value of metabolic parameters determined by preoperative (1)(8)F-FDG PET/CT in patients with uterine carcinosarcoma.
    J Gynecol Oncol. 2017;28:e43.
    Abstract     Related articles   

  84. PRETI M, Bucchi L, Ghiringhello B, Privitera S, et al
    Risk factors for unrecognized invasive carcinoma in patients with vulvar high-grade squamous intraepithelial lesion at vulvoscopy-directed biopsy.
    J Gynecol Oncol. 2017;28:e27.
    Abstract     Related articles   

  85. CREMER M, Paul P, Bergman K, Haas M, et al
    A Non-Gas-Based Cryotherapy System for the Treatment of Cervical Intraepithelial Neoplasia: A Mixed-Methods Approach for Initial Development and Testing.
    Glob Health Sci Pract. 2017;5:57-64.
    Abstract     Related articles   

  86. PENG J, Wang W, Zeng D
    Application of magnetic resonance imaging in diagnosis of Uterus Cervical Carcinoma.
    J Xray Sci Technol. 2017;25:205-211.
    Abstract     Related articles   

  87. SHAW W, Rae WID, Alber ML
    Image-guided adaptive brachytherapy dose escalation for cervix cancer via fractionation compensation.
    Brachytherapy. 2017;16:534-546.
    Abstract     Related articles   

  88. LAI D, Bodson J, Davis FA, Lee D, et al
    Diverse Families' Experiences with HPV Vaccine Information Sources: A Community-Based Participatory Approach.
    J Community Health. 2017;42:400-412.
    Abstract     Related articles   

  89. MATTINGLY M, Juran R, Su I, Ebinger J, et al
    Patient knowledge of hysterectomy and pap screening after minimally invasive hysterectomy.
    Patient Educ Couns. 2017;100:121-125.
    Abstract     Related articles   

  90. KELLY PJ, Hunter J, Daily EB, Ramaswamy M, et al
    Challenges to Pap Smear Follow-up among Women in the Criminal Justice System.
    J Community Health. 2017;42:15-20.
    Abstract     Related articles   

  91. DUAN C, Kallehauge JF, Bretthorst GL, Tanderup K, et al
    Are complex DCE-MRI models supported by clinical data?
    Magn Reson Med. 2017;77:1329-1339.
    Abstract     Related articles   

  92. WANG X, Jiang Z, An J, Mao X, et al
    Effect of a synthetic inhibitor of urokinase plasminogen activator on the migration and invasion of human cervical cancer cells in vitro.
    Mol Med Rep. 2018 Jan 9. doi: 10.3892/mmr.2018.8414.
    Abstract     Related articles   

  93. WANG L, Chai L, Ji Q, Cheng R, et al
    Forkhead box protein C1 promotes cell proliferation and invasion in human cervical cancer.
    Mol Med Rep. 2018 Jan 11. doi: 10.3892/mmr.2018.8423.
    Abstract     Related articles   

  94. WANG LN, Wang F, Liu J, Jin YH, et al
    CYP1A1 Ile462Val Polymorphism Is Associated with Cervical Cancer Risk in Caucasians Not Asians: A Meta-Analysis.
    Front Physiol. 2017;8:1081.
    Abstract     Related articles   

  95. HUI BB, Reulein CP, Guy RJ, Donovan B, et al
    Impact of replacing cytology with human papillomavirus testing for cervical cancer screening on the prevalence of Trichomonas vaginalis: a modelling study.
    Sex Transm Infect. 2018 Jan 11. pii: sextrans-2017-053294.
    Abstract     Related articles   

  96. ISLAM JY, Khatun F, Alam A, Sultana F, et al
    Knowledge of cervical cancer and HPV vaccine in Bangladeshi women: a population based, cross-sectional study.
    BMC Womens Health. 2018;18:15.
    Abstract     Related articles   

  97. JASSIM G, Obeid A, Al Nasheet HA
    Knowledge, attitudes, and practices regarding cervical cancer and screening among women visiting primary health care Centres in Bahrain.
    BMC Public Health. 2018;18:128.
    Abstract     Related articles   

  98. CHOI Y, Ahn KJ, Park SK, Cho H, et al
    Correction: Adverse effect of excess body weight on survival in cervical cancer patients after surgery and radiotherapy.
    Radiat Oncol J. 2017;35:385.
    Abstract     Related articles   

  99. OLOLADE K, Mokgoro NP, Lawal IO, Vorster M, et al
    A comparison of (18)F-FDG PET/CT findings in HIV positive compared to HIV negative patients with recurrent cervical cancer.
    Hell J Nucl Med. 2017;20 Suppl:71-79.
    Abstract     Related articles   

  100. JIANG L, Shi S, Shi Q, Zhang H, et al
    MicroRNA-519d-3p inhibits proliferation and promotes apoptosis by targeting HIF-2alpha in cervical cancer under hypoxic conditions.
    Oncol Res. 2018 Jan 10. doi: 10.3727/096504018X15152056890500.
    Abstract     Related articles   

  101. SAETERDAL I, Juvet LK, Natvig Norderhaug I, Liu Q, et al
    The overexpression of PXN promotes tumor progression and leads to radioresistance in cervical cancer.
    Future Oncol. 2018 Jan 10. doi: 10.2217/fon-2017-0474.
    Abstract     Related articles   

  102. VALENTINI AL, Micco M, Gui B, Giuliani M, et al
    The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery.
    Eur Radiol. 2018 Jan 9. pii: 10.1007/s00330-017-5233.
    Abstract     Related articles   

  103. TAX C, Abbink K, Rovers MM, Bekkers RLM, et al
    Para-aortic lymphadenectomy in advanced stage cervical cancer, a protocol for comparing safety, feasibility and diagnostic accuracy of surgical staging versus PET-CT; PALDISC trial.
    Pilot Feasibility Stud. 2018;4:27.
    Abstract     Related articles   

  104. MINAMI H, Nagasaki T, Akiyoshi T, Konishi T, et al
    Laparoscopic repair of bowel herniation into the space between the obturator nerve and the umbilical artery after pelvic lymphadenectomy for cervical cancer.
    Asian J Endosc Surg. 2018 Jan 4. doi: 10.1111/ases.12458.
    Abstract     Related articles   

  105. LI L, Sun JX, Wang XQ, Liu XK, et al
    Notoginsenoside R7 suppresses cervical cancer via PI3K/PTEN/Akt/mTOR signaling.
    Oncotarget. 2017;8:109487-109496.
    Abstract     Related articles   

  106. LONG NP, Jung KH, Yoon SJ, Anh NH, et al
    Systematic assessment of cervical cancer initiation and progression uncovers genetic panels for deep learning-based early diagnosis and proposes novel diagnostic and prognostic biomarkers.
    Oncotarget. 2017;8:109436-109456.
    Abstract     Related articles   

  107. SEABRA MAL, Candido EB, Vidigal PVT, Lamaita RM, et al
    Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer.
    Rev Bras Ginecol Obstet. 2018 Jan 8. doi: 10.1055/s-0037-1618597.
    Abstract     Related articles   

  108. NGUYEN-TRUONG CKY, Hassouneh D, Lee-Lin F, Hsiao CY, et al
    Health Care Providers' Perspectives on Barriers and Facilitators to Cervical Cancer Screening in Vietnamese American Women.
    J Transcult Nurs. 2017 Dec 1:1043659617745135. doi: 10.1177/1043659617745135.
    Abstract     Related articles   

  109. YANG Y, Liu Y, Li G, Li L, et al
    Vaginal Stump Ligation for Cervical Cancer.
    Iran J Public Health. 2017;46:1332-1337.
    Abstract     Related articles   

  110. LI H, Duan D, Xu J, Gong Q, et al
    The Incidence and Mortality of Cervical Cancer in Ningbo during 2006-2014, China.
    Iran J Public Health. 2017;46:1324-1331.
    Abstract     Related articles   

  111. GINSBURG O, Paskett ED
    Ethnic and racial disparities in cervical cancer: lessons from a modelling study of cervical cancer prevention.
    Lancet Public Health. 2018;3:e8-e9.
    Abstract     Related articles   

  112. WENTZENSEN N, Schiffman M
    Accelerating cervical cancer control and prevention.
    Lancet Public Health. 2018;3:e6-e7.
    Abstract     Related articles   

  113. JOHNSON HC, Lafferty EI, Eggo RM, Louie K, et al
    Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study.
    Lancet Public Health. 2018;3:e44-e51.
    Abstract     Related articles   

  114. CASTANON A, Landy R, Pesola F, Windridge P, et al
    Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study.
    Lancet Public Health. 2018;3:e34-e43.
    Abstract     Related articles   

  115. DISIS MLN
    Movie Review of The Immortal Life of Henrietta Lacks.
    JAMA. 2017;318:2410-2412.
    Abstract     Related articles   

  116. LIU L, Chen LM, Tao X, Dai F, et al
    [Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:751-756.
    Abstract     Related articles   

  117. HE Y, Wu YM, Yin CH, Geng YN, et al
    [Natural changes of high-risk HPV in women with negative for intraepithelial lesion or malignancy: a prospective 1 year study].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:740-744.
    Abstract     Related articles   

  118. WU Y, Zhao J, Hu J, Wu XW, et al
    [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:734-739.
    Abstract     Related articles   

  119. NASIOUDIS D, Alevizakos M, Chapman-Davis E, Witkin SS, et al
    Rhabdomyosarcoma of the lower female genital tract: an analysis of 144 cases.
    Arch Gynecol Obstet. 2017;296:327-334.
    Abstract     Related articles   

  120. ORTEGA O, Ondo-Mendez A, Garzon R
    [STAT3 activation by hypoxia in in vitro models of cervix cancer and endothelial cells].
    Biomedica. 2017;37:119-130.
    Abstract     Related articles   

  121. LIN J, Chen L, Qiu X, Zhang N, et al
    Traditional Chinese medicine for human papillomavirus (HPV) infections: A systematic review.
    Biosci Trends. 2017;11:267-273.
    Abstract     Related articles   

  122. VARAN C, Wickstrom H, Sandler N, Aktas Y, et al
    Inkjet printing of antiviral PCL nanoparticles and anticancer cyclodextrin inclusion complexes on bioadhesive film for cervical administration.
    Int J Pharm. 2017;531:701-713.
    Abstract     Related articles   

  123. MACH CM, Kha C, Nguyen D, Shumway J, et al
    A retrospective evaluation of furosemide and mannitol for prevention of cisplatin-induced nephrotoxicity.
    J Clin Pharm Ther. 2017;42:286-291.
    Abstract     Related articles   

  124. CHANDRA J, Dutton JL, Li B, Woo WP, et al
    DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection.
    J Immunother. 2017;40:62-70.
    Abstract     Related articles   

  125. RAGONNAUD E, Andersson AC, Mariya S, Pedersen AG, et al
    Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix.
    J Immunother. 2017;40:51-61.
    Abstract     Related articles   

  126. ZIEMKE P, Griesser H
    [Indications for p16/Ki-67 in cervical cytology].
    Pathologe. 2017;38:38-44.
    Abstract     Related articles   

  127. LIN M, Yu X, Chen Y, Ouyang H, et al
    Contribution of mono-exponential, bi-exponential and stretched exponential model-based diffusion-weighted MR imaging in the diagnosis and differentiation of uterine cervical carcinoma.
    Eur Radiol. 2017;27:2400-2410.
    Abstract     Related articles   

  128. GELOVER E, Katherine C, Mart C, Sun W, et al
    Patient's specific integration of OAR doses (D2 cc) from EBRT and 3D image-guided brachytherapy for cervical cancer.
    J Appl Clin Med Phys. 2018 Jan 19. doi: 10.1002/acm2.12247.
    Abstract     Related articles   

  129. KHANAM R, Kumar R, Hejazi II, Shahabuddin S, et al
    Piperazine clubbed with 2-azetidinone derivatives suppresses proliferation, migration and induces apoptosis in human cervical cancer HeLa cells through oxidative stress mediated intrinsic mitochondrial pathway.
    Apoptosis. 2018 Jan 18. pii: 10.1007/s10495-018-1439.
    Abstract     Related articles   

  130. HATA M, Koike I, Miyagi E, Numazaki R, et al
    Radiation therapy for stage IVA uterine cervical cancer: treatment outcomes including prognostic factors and risk of vesicovaginal and rectovaginal fistulas.
    Oncotarget. 2017;8:112855-112866.
    Abstract     Related articles   

  131. BASU BAUL TS, Longkumer I, Duthie A, Singh P, et al
    Triphenylstannyl((arylimino)methyl)benzoates with selective potency that induce G1 and G2/M cell cycle arrest and trigger apoptosis via ROS in human cervical cancer cells.
    Dalton Trans. 2018 Jan 18. doi: 10.1039/c7dt04037.
    Abstract     Related articles   

  132. YUAN Y, Ye HQ, Ren QC
    Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer.
    Int J Oncol. 2018;52:461-472.
    Abstract     Related articles   

  133. SATO N, Saga Y, Uchibori R, Tsukahara T, et al
    Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7.
    Int J Oncol. 2018 Jan 15. doi: 10.3892/ijo.2018.4245.
    Abstract     Related articles   

  134. CHEN HH, Chen SP, Zheng QL, Nie SP, et al
    Genistein Promotes Proliferation of Human Cervical Cancer Cells Through Estrogen Receptor-Mediated PI3K/Akt-NF-kappaB Pathway.
    J Cancer. 2018;9:288-295.
    Abstract     Related articles   

  135. ZHANG B, Wei CY, Chang KK, Yu JJ, et al
    TSLP promotes angiogenesis of human umbilical vein endothelial cells by strengthening the crosstalk between cervical cancer cells and eosinophils.
    Oncol Lett. 2017;14:7483-7488.
    Abstract     Related articles   

  136. ZHAO J, Li B, Shu C, Ma Y, et al
    Downregulation of miR-30a is associated with proliferation and invasion via targeting MEF2D in cervical cancer.
    Oncol Lett. 2017;14:7437-7442.
    Abstract     Related articles   

  137. ZHANG Y, Zhu W, Zhang X, Qu Q, et al
    Expression and clinical significance of programmed death-1 on lymphocytes and programmed death ligand-1 on monocytes in the peripheral blood of patients with cervical cancer.
    Oncol Lett. 2017;14:7225-7231.
    Abstract     Related articles   

  138. OUYANG Y, Wang Y, Chen K, Cao X, et al
    Clinical outcome of extended-field irradiation vs. pelvic irradiation using intensity-modulated radiotherapy for cervical cancer.
    Oncol Lett. 2017;14:7069-7076.
    Abstract     Related articles   

  139. POUDYAL D, Herman A, Adelsberger JW, Yang J, et al
    A novel microRNA, hsa-miR-6852 differentially regulated by Interleukin-27 induces necrosis in cervical cancer cells by downregulating the FoxM1 expression.
    Sci Rep. 2018;8:900.
    Abstract     Related articles   

  140. ABULIZI G, Abulimiti T, Li H, Abuduxikuer G, et al
    Knowledge of cervical cancer and Pap smear among Uyghur women from Xinjiang, China.
    BMC Womens Health. 2018;18:21.
    Abstract     Related articles   

  141. LUO Q, Luo L, Tang L
    A Network Meta-Analysis on the Diagnostic Value of Different Imaging Methods for Lymph Node Metastases in Patients With Cervical Cancer.
    Technol Cancer Res Treat. 2018;17:1533034617742311.
    Abstract     Related articles   

    [Screening program for cervical cancer: public policies and experiences of actors who implement the program in the state of Veracruz, Mexico].
    Salud Colect. 2017;13:521-535.
    Abstract     Related articles   

  143. NDIZEYE Z, Vanden Broeck D, Vermandere H, Bogers JP, et al
    Knowledge and practices of general practitioners at district hospitals towards cervical cancer prevention in Burundi, 2015: a cross-sectional study.
    Global Health. 2018;14:4.
    Abstract     Related articles   

  144. BABAZADEH T, Nadrian H, Moghaddam HR, Ezzati E, et al
    Cognitive determinants of cervical cancer screening behavior amongst housewife women in Iran: an application of Health Belief Model.
    Health Care Women Int. 2018 Jan 17:0. doi: 10.1080/07399332.2018.1425873.
    Abstract     Related articles   

  145. LIU M, Jia J, Wang X, Liu Y, et al
    Long non-coding RNA HOTAIR promotes cervical cancer progression through regulating BCL2 via targeting miR-143-3p.
    Cancer Biol Ther. 2018 Jan 16:0. doi: 10.1080/15384047.2018.1423921.
    Abstract     Related articles   

  146. LI Q, Feng Y, Chao X, Shi S, et al
    HOTAIR contributes to cell proliferation and metastasis of cervical cancer via targeting miR-23b/MAPK1 axis.
    Biosci Rep. 2018 Jan 15. pii: BSR20171563. doi: 10.1042/BSR20171563.
    Abstract     Related articles   

  147. WILLIAMS MS, Kenu E, Dzubey I, Dennis-Antwi JA, et al
    A qualitative study of cervical cancer and cervical cancer screening awareness among Nurses in Ghana.
    Health Care Women Int. 2018 Jan 15:0. doi: 10.1080/07399332.2018.1424169.
    Abstract     Related articles   

  148. WANG Y, Wang Y, Zhong W, Gulina K, et al
    Correlation between miR-19a inhibition and radiosensitivity in SiHa cervical cancer cells.
    J BUON. 2017;22:1505-1508.
    Abstract     Related articles   

  149. PAN Q, Liu R, Banu H, Ma L, et al
    Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway.
    Biomed Pharmacother. 2018;99:169-175.
    Abstract     Related articles   

  150. CHAPMAN CH, Polan D, Vineberg K, Jolly S, et al
    Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
    Brachytherapy. 2018 Jan 10. pii: S1538-4721(17)30540.
    Abstract     Related articles   

  151. XU HH, Zheng LZ, Lin AF, Dong SS, et al
    Human papillomavirus (HPV) 18 genetic variants and cervical cancer risk in Taizhou area, China.
    Gene. 2018 Jan 10. pii: S0378-1119(18)30045-3. doi: 10.1016/j.gene.2018.
    Abstract     Related articles   

  152. SAETERDAL I, Juvet LK, Natvig Norderhaug I
    Update on current care guideline: Cytological changes in the cervix, vagina and vulva.
    Duodecim. 2017;133:183-5.
    Abstract     Related articles   

  153. TAO G, Yaling G, Zhan G, Pu L, et al
    Human papillomavirus genotype distribution among HPV-positive women in Sichuan province, Southwest China.
    Arch Virol. 2018;163:65-72.
    Abstract     Related articles   

  154. HAMEED A, Dekovich AA, Lum PJ, Shafi MA, et al
    Dysphagia: An Unusual Presentation of Metastatic Uterine Cervical Carcinoma.
    J Coll Physicians Surg Pak. 2017;27:187-188.
    Abstract     Related articles   

  155. SHEN-GUNTHER J, Wang Y, Lai Z, Poage GM, et al
    Deep sequencing of HPV E6/E7 genes reveals loss of genotypic diversity and gain of clonal dominance in high-grade intraepithelial lesions of the cervix.
    BMC Genomics. 2017;18:231.
    Abstract     Related articles   

  156. TRAN AQ, Sullivan SA, Gehrig PA, Soper JT, et al
    Robotic Radical Parametrectomy With Upper Vaginectomy and Pelvic Lymphadenectomy in Patients With Occult Cervical Carcinoma After Extrafascial Hysterectomy.
    J Minim Invasive Gynecol. 2017;24:757-763.
    Abstract     Related articles   

  157. PLATH J, Siebenhofer A, Kone I, Hechtner M, et al
    Frequency of a positive family history of colorectal cancer in general practice: a cross-sectional study.
    Fam Pract. 2017;34:30-35.
    Abstract     Related articles   

    Comments on prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
    Am J Obstet Gynecol. 2017;216:197-198.
    Abstract     Related articles   

  159. SHAIN AF, Kwok S, Folkins AK, Kong CS, et al
    Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
    Am J Surg Pathol. 2018;42:69-75.
    Abstract     Related articles   

  160. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    Abstract     Related articles   

  161. CHOI YW, Kang MC, Seo YB, Namkoong H, et al
    Intravaginal administration of Fc-fused IL-7 suppresses the cervicovaginal tumor by recruiting HPV DNA vaccine-induced CD8 T cells.
    Clin Cancer Res. 2016 Jul 12. pii: clincanres.0423.2016.
    Abstract     Related articles   

  162. PEDERSEN K, Burger EA, Nygard M, Kristiansen IS, et al
    Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.
    Eur J Cancer. 2018;91:68-75.
    Abstract     Related articles   

  163. XIANG L, Jiang W, Ye S, He T, et al
    ERBB2 mutation: A promising target in non-squamous cervical cancer.
    Gynecol Oncol. 2017 Dec 23. pii: S0090-8258(17)31614.
    Abstract     Related articles   

  164. LEE J, Lin JB, Chang CL, Sun FJ, et al
    Impact of para-aortic recurrence risk-guided intensity-modulated radiotherapy in locally advanced cervical cancer with positive pelvic lymph nodes.
    Gynecol Oncol. 2017 Dec 18. pii: S0090-8258(17)31550.
    Abstract     Related articles   

  165. BACORRO W, Dumas I, Escande A, Gouy S, et al
    Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer.
    Gynecol Oncol. 2018 Jan 8. pii: S0090-8258(17)31621.
    Abstract     Related articles   

  166. PARK SH, Cheon H, Chong GO, Jeong SY, et al
    Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.
    Gynecol Oncol. 2018 Jan 9. pii: S0090-8258(18)30037.
    Abstract     Related articles   

  167. MANCINI S, Ravaioli A, Giuliani O, Vattiato R, et al
    Incidence and survival trends of cervical adenocarcinoma in Italy: Cytology screening has become more effective in downstaging the disease but not in detecting its precursors.
    Int J Cancer. 2017;140:247-248.
    Abstract     Related articles   

  168. DE KOK IMCM, Korfage IJ, van den Hout WB, Helmerhorst TJM, et al
    Quality of life assumptions determine which cervical cancer screening strategies are cost-effective.
    Int J Cancer. 2018 Jan 19. doi: 10.1002/ijc.31265.
    Abstract     Related articles   

  169. CHONG GO, Lee YH, Lee HJ, Hong DG, et al
    Comparison of the Long-Term Oncological Outcomes Between the Initial Learning Period of Robotic and the Experienced Period of Laparoscopic Radical Hysterectomy for Early-Stage Cervical Cancer.
    Int J Gynecol Cancer. 2018 Jan 4. doi: 10.1097/IGC.0000000000001172.
    Abstract     Related articles   

  170. GUO X, Dong Z, Yamada S, Li Y, et al
    Association of Casp3 microRNA Target Site (1049216) SNP With the Risk and Progress of Cervical Squamous Cell Carcinoma.
    Int J Gynecol Cancer. 2017;27:206-213.
    Abstract     Related articles   

  171. HARTMAN CA, Teixeira JC, Barbosa SB, Figueiredo SM, et al
    Analysis of Conservative Surgical Treatment and Prognosis of Microinvasive Squamous Cell Carcinoma of the Cervix Stage IA1: Results of Follow-Up to 20 Years.
    Int J Gynecol Cancer. 2017;27:357-363.
    Abstract     Related articles   

  172. O'DONNELL B, Shiao JC, Pezzi TA, Waheed N, et al
    Stereotactic Body Radiation Therapy, Intensity-Modulated Radiation Therapy, and Brachytherapy Boost Modalities in Invasive Cervical Cancer: A Study of the National Cancer Data Base.
    Int J Gynecol Cancer. 2018 Jan 10. doi: 10.1097/IGC.0000000000001200.
    Abstract     Related articles   

  173. DEVOR EJ, Reyes HD, Gonzalez-Bosquet J, Warrier A, et al
    Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology.
    Int J Gynecol Cancer. 2017;27:784-790.
    Abstract     Related articles   

  174. SLAMA J, Fischerova D, Zikan M, Kocian R, et al
    Sensitivity of Follow-Up Methods in Patients After Fertility-Sparing Surgery for Cervical Cancers.
    Int J Gynecol Cancer. 2017;27:147-153.
    Abstract     Related articles   

  175. MAHANTSHETTY U, Krishnatry R, Hande V, Jamema S, et al
    Magnetic Resonance Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: An Experience From a Tertiary Cancer Center in a Low and Middle Income Countries Setting.
    Int J Radiat Oncol Biol Phys. 2017;99:608-617.
    Abstract     Related articles   

  176. GLASER S, Mahantshetty U, Lee L, Klopp A, et al
    Genomics and 3-Dimensional Brachytherapy for Cervical Cancer: Significant Steps Forward.
    Int J Radiat Oncol Biol Phys. 2017;99:505-509.
    Abstract     Related articles   

  177. DOUTRE S, Omar T, Goumbri-Lompo O, Kelly H, et al
    Cervical intraepithelial neoplasia (CIN) in African women living with HIV: role and effect of rigorous histopathological review by a panel of pathologists in the HARP study endpoint determination.
    J Clin Pathol. 2018;71:40-45.
    Abstract     Related articles   

  178. LEINONEN MK, Schee K, Jonassen CM, Lie AK, et al
    Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions.
    J Clin Virol. 2017;99-100:22-30.
    Abstract     Related articles   

  179. GHOSH I, Muwonge R, Mittal S, Banerjee D, et al
    Association between high risk human papillomavirus infection and co-infection with Candida spp. and Trichomonas vaginalis in women with cervical premalignant and malignant lesions.
    J Clin Virol. 2017;87:43-48.
    Abstract     Related articles   

  180. SILVERBERG MJ, Leyden WA, Chi A, Gregorich S, et al
    Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia.
    Obstet Gynecol. 2018;131:47-55.
    Abstract     Related articles   

  181. SHI X, Ran L, Liu Y, Zhong SH, et al
    Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Oncol Rep. 2018 Jan 5. doi: 10.3892/or.2018.6195.
    Abstract     Related articles   

  182. LI C, Zheng X, Li W, Bai F, et al
    Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
    BMC Cancer. 2018;18:61.
    Abstract     Related articles   

  183. Correction: Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0190661.
    Abstract     Related articles   

  184. ANDERSSON S, Belkic K, Demirbuker SS, Mints M, et al
    Perceived cervical cancer risk among women treated for high-grade cervical intraepithelial neoplasia: The importance of specific knowledge.
    PLoS One. 2017;12:e0190156.
    Abstract     Related articles   

  185. DA SILVA ERP, de Souza AS, de Souza TGB, Tsuha DH, et al
    Screening for cervical cancer in imprisoned women in Brazil.
    PLoS One. 2017;12:e0187873.
    Abstract     Related articles   

  186. BADANO I, Sanabria DJ, Totaro ME, Rubinstein S, et al
    Mitochondrial DNA ancestry, HPV infection and the risk of cervical cancer in a multiethnic population of northeastern Argentina.
    PLoS One. 2018;13:e0190966.
    Abstract     Related articles   

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.